Salspera
SciencePipelineOur DataTeamNews & PublicationsFAQContact
  1. FAQ
  2. ›
  3. Pipeline & regulatory

Is there a Phase 3 trial of Saltikva?

A pivotal Phase 3 of Saltikva in stage IV pancreatic cancer is planned following an FDA Type C meeting, but it is not yet active or recruiting, and none is registered on ClinicalTrials.gov ↗.

  • Salspera, Inc. Form S-1/A No. 3, filed 2026-03-20 ↗
  • ClinicalTrials.gov NCT04589234 (Phase 2) ↗
Last reviewed 2026-11-05
All questions in this categoryAll 65 questions
SalsperaA privately held, privately funded biopharma company developing Saltikva® and a pipeline of microbial immunotherapies for solid tumors.
CompanyScienceOur DataPipelineTeam
UpdatesNews & PublicationsFAQContactmedia@salspera.com
Legal© 2026 Salspera, Inc. All rights reserved. Saltikva® is a registered trademark of Salspera, Inc. Saltikva® is an investigational therapy and has not been approved by any regulatory authority. Clinical results are from a single-arm, non-randomized study. Statements about future plans are forward-looking.